Review




Structured Review

National Research Council Canada human fascin1
Human Fascin1, supplied by National Research Council Canada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+fascin1/10__1107_slash_s2053230x25005254-10-24-85?v=National+Research+Council+Canada
Average 90 stars, based on 1 article reviews
human fascin1 - by Bioz Stars, 2026-08
90/100 stars

Images



Similar Products

90
National Research Council Canada human fascin1
Human Fascin1, supplied by National Research Council Canada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+fascin1/10__1107_slash_s2053230x25005254-10-24-85?v=National+Research+Council+Canada
Average 90 stars, based on 1 article reviews
human fascin1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

91
Addgene inc human fascin1
Human Fascin1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+fascin1/bio_rxiv__2024__01__03__574123-214-4-11?v=Addgene+inc
Average 91 stars, based on 1 article reviews
human fascin1 - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

90
OriGene fascin1
Fascin1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+fascin1/us10759836-1675-84-86?v=OriGene
Average 90 stars, based on 1 article reviews
fascin1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Danaher Inc mouse monoclonal antibodies to human fascin1 (epitomics, burlingame, ca, usa; 1:100)
The association between <t> fascin1 </t> expression and clinicopathologic parameters of patients with high-grade ovarian serous carcinoma.
Mouse Monoclonal Antibodies To Human Fascin1 (Epitomics, Burlingame, Ca, Usa; 1:100), supplied by Danaher Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+fascin1/pmc03928475-85-25-27?v=Danaher+Inc
Average 90 stars, based on 1 article reviews
mouse monoclonal antibodies to human fascin1 (epitomics, burlingame, ca, usa; 1:100) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


The association between  fascin1  expression and clinicopathologic parameters of patients with high-grade ovarian serous carcinoma.

Journal: International Journal of Oncology

Article Title: Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells

doi: 10.3892/ijo.2013.2232

Figure Lengend Snippet: The association between fascin1 expression and clinicopathologic parameters of patients with high-grade ovarian serous carcinoma.

Article Snippet: After three rinses in phosphate-buffered saline (PBS) for 5 min, each section was incubated for 1 h at room temperature with mouse monoclonal antibodies to human fascin1 (Epitomics, Burlingame, CA, USA; 1:100), and human β-catenin (Novus Biologicals, Littleton, CO, USA) all diluted in PBS; washed three times in PBS for 5 min; incubated with horseradish peroxidase-labeled rabbit anti-mouse immunoglobulin (DAKO; 1 h at room temperature); washed three times; and incubated with a solution of diaminobenzidine (DAB) at room temperature to visualize peroxidase activity.

Techniques: Expressing

Representative immunohistochemical analysis of the fascin1 and β-catenin expression. (A) Fascin1 was negative in the epithelial cells of the fallopian tube (negative control) and immunopositive in the endothelial cells (positive control) and (B) positive staining in cytoplasm of tumor cells of the high-grade ovarian serous carcinoma. β-catenin was observed clear membrane staining in all the cases of (C) fallopian tube and of (D) high-grade ovarian serous carcinoma.

Journal: International Journal of Oncology

Article Title: Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells

doi: 10.3892/ijo.2013.2232

Figure Lengend Snippet: Representative immunohistochemical analysis of the fascin1 and β-catenin expression. (A) Fascin1 was negative in the epithelial cells of the fallopian tube (negative control) and immunopositive in the endothelial cells (positive control) and (B) positive staining in cytoplasm of tumor cells of the high-grade ovarian serous carcinoma. β-catenin was observed clear membrane staining in all the cases of (C) fallopian tube and of (D) high-grade ovarian serous carcinoma.

Article Snippet: After three rinses in phosphate-buffered saline (PBS) for 5 min, each section was incubated for 1 h at room temperature with mouse monoclonal antibodies to human fascin1 (Epitomics, Burlingame, CA, USA; 1:100), and human β-catenin (Novus Biologicals, Littleton, CO, USA) all diluted in PBS; washed three times in PBS for 5 min; incubated with horseradish peroxidase-labeled rabbit anti-mouse immunoglobulin (DAKO; 1 h at room temperature); washed three times; and incubated with a solution of diaminobenzidine (DAB) at room temperature to visualize peroxidase activity.

Techniques: Immunohistochemical staining, Expressing, Negative Control, Positive Control, Staining, Membrane

Kaplan-Meier survival analysis of progression-free survival in all patients according to fascin1 expression. Significant differences among the subgroups with positive (dimed line) and negative (bold line) fascin1 expression indicate poor outcomes in patients with fascin1 expression group. Fascin1 expression group was significantly correlated with shorter progression-free survival (P<0.001). The log-rank test yielded significant P-values.

Journal: International Journal of Oncology

Article Title: Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells

doi: 10.3892/ijo.2013.2232

Figure Lengend Snippet: Kaplan-Meier survival analysis of progression-free survival in all patients according to fascin1 expression. Significant differences among the subgroups with positive (dimed line) and negative (bold line) fascin1 expression indicate poor outcomes in patients with fascin1 expression group. Fascin1 expression group was significantly correlated with shorter progression-free survival (P<0.001). The log-rank test yielded significant P-values.

Article Snippet: After three rinses in phosphate-buffered saline (PBS) for 5 min, each section was incubated for 1 h at room temperature with mouse monoclonal antibodies to human fascin1 (Epitomics, Burlingame, CA, USA; 1:100), and human β-catenin (Novus Biologicals, Littleton, CO, USA) all diluted in PBS; washed three times in PBS for 5 min; incubated with horseradish peroxidase-labeled rabbit anti-mouse immunoglobulin (DAKO; 1 h at room temperature); washed three times; and incubated with a solution of diaminobenzidine (DAB) at room temperature to visualize peroxidase activity.

Techniques: Expressing

Fascin1 expression after siRNA transfection. (A) Real-time PCR analysis revealed the fascin1 expression was inhibited in the cancer cells transfected with fascin1 siRNA compared with control cancer cells (P<0.001). (B) Western blot analysis showed fascin1 siRNA inhibited fascin1 expression compared with control cancer cells. β-actin was detected as a loading control (P<0.001).

Journal: International Journal of Oncology

Article Title: Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells

doi: 10.3892/ijo.2013.2232

Figure Lengend Snippet: Fascin1 expression after siRNA transfection. (A) Real-time PCR analysis revealed the fascin1 expression was inhibited in the cancer cells transfected with fascin1 siRNA compared with control cancer cells (P<0.001). (B) Western blot analysis showed fascin1 siRNA inhibited fascin1 expression compared with control cancer cells. β-actin was detected as a loading control (P<0.001).

Article Snippet: After three rinses in phosphate-buffered saline (PBS) for 5 min, each section was incubated for 1 h at room temperature with mouse monoclonal antibodies to human fascin1 (Epitomics, Burlingame, CA, USA; 1:100), and human β-catenin (Novus Biologicals, Littleton, CO, USA) all diluted in PBS; washed three times in PBS for 5 min; incubated with horseradish peroxidase-labeled rabbit anti-mouse immunoglobulin (DAKO; 1 h at room temperature); washed three times; and incubated with a solution of diaminobenzidine (DAB) at room temperature to visualize peroxidase activity.

Techniques: Expressing, Transfection, Real-time Polymerase Chain Reaction, Control, Western Blot

The inactivation of fascin1 inhibits proliferation and invasive ability of ovarian cancer cell lines SKOV3, and OVCAR3. (A) Cell proliferation was measured by colony forming assay after fascin1 siRNA transfection. The colony formation of the transfected cells grew significantly slower than control cells at 72 h. Colony numbers of transfected cells decreased significantly to 95.7% (SKOV3), 78.1% (OVCAR3) compared with that in control cells (72 h) (P<0.05). (B) Wound-healing assays were performed to examine the effect of fascin1 inactivation on cell migration (×100). The migration activities of the transfected cells were decreased 51.3% (SKOV3), and 55.3% (OVCAR3) compared to control cells at 16 h (P<0.05). (C) Matrigel invasion assays were performed to examine the effect of fascin1 on cell invasion (×100). Diagram of the cell count in the membrane. Fascin1 siRNA transfected cells led to 35.8% (SKOV3), and 31.1% (OVCAR3) decrease in the number of invasive cells (P<0.05). The above results are from 3 independent experiments.

Journal: International Journal of Oncology

Article Title: Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells

doi: 10.3892/ijo.2013.2232

Figure Lengend Snippet: The inactivation of fascin1 inhibits proliferation and invasive ability of ovarian cancer cell lines SKOV3, and OVCAR3. (A) Cell proliferation was measured by colony forming assay after fascin1 siRNA transfection. The colony formation of the transfected cells grew significantly slower than control cells at 72 h. Colony numbers of transfected cells decreased significantly to 95.7% (SKOV3), 78.1% (OVCAR3) compared with that in control cells (72 h) (P<0.05). (B) Wound-healing assays were performed to examine the effect of fascin1 inactivation on cell migration (×100). The migration activities of the transfected cells were decreased 51.3% (SKOV3), and 55.3% (OVCAR3) compared to control cells at 16 h (P<0.05). (C) Matrigel invasion assays were performed to examine the effect of fascin1 on cell invasion (×100). Diagram of the cell count in the membrane. Fascin1 siRNA transfected cells led to 35.8% (SKOV3), and 31.1% (OVCAR3) decrease in the number of invasive cells (P<0.05). The above results are from 3 independent experiments.

Article Snippet: After three rinses in phosphate-buffered saline (PBS) for 5 min, each section was incubated for 1 h at room temperature with mouse monoclonal antibodies to human fascin1 (Epitomics, Burlingame, CA, USA; 1:100), and human β-catenin (Novus Biologicals, Littleton, CO, USA) all diluted in PBS; washed three times in PBS for 5 min; incubated with horseradish peroxidase-labeled rabbit anti-mouse immunoglobulin (DAKO; 1 h at room temperature); washed three times; and incubated with a solution of diaminobenzidine (DAB) at room temperature to visualize peroxidase activity.

Techniques: Transfection, Control, Migration, Cell Counting, Membrane